Affiliations
AffiliationsItem in Clipboard
Patients' and Health Care Providers' Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative EvaluationDanny A Young-Afat et al. JMIR Cancer. 2016.
doi: 10.2196/cancer.5334. Authors Danny A Young-Afat 1 , Carla H van Gils 1 , David J Bruinvels 2 , Carmen C van der Pol 3 , Arjen J Witkamp 3 , Sieta Sijtsema 3 , Yvette Jonasse 4 , Rhodé M Bijlsma 5 , Margreet G Ausems 6 , Annelies M Bos 7 , Desirée H van den Bongard 8 , Helena M Verkooijen 9 AffiliationsItem in Clipboard
AbstractBackground: Health apps are increasingly being used in clinical care and may hold significant theoretical potential. However, they are often implemented in clinical care before any research has been done to confirm actual benefits for patients, physicians, and researchers.
Objective: This study aimed to explore experiences of patients and health care providers with the use of a supportive breast cancer app during the first 6 months following diagnosis, in terms of benefits for clinical practice and research purposes.
Methods: Between June 2013 and April 2014, breast cancer patients of all ages were invited shortly after diagnosis to use a supportive breast cancer app, and were followed for 6 months. Patients were asked to use the app at their own convenience. In-depth interviews were conducted regularly with patients and their medical team (ie, physicians and nurses) to evaluate their experiences.
Results: A total of 15 patients aged 30-63 years participated. The medical team consisted of 7 physicians and 3 specialized breast cancer nurses. Out of the 15 patients, 12 (80%) used the app to obtain information on breast cancer and treatment. A total of 11 out of 12 patients (92%) evaluated this information as useful. All 15 patients used the app to record consultations with practitioners, and 14 (93%) found this useful. Symptom registration was used by 8 out of 15 patients (53%), and was found useful by 4 out of these 8 patients (50%). Overall, 14 out of 15 patients (93%) would recommend the app to other patients. The app, in particular the recording function, was rated as useful by 9 out of 10 medical professionals (90%), and they reported that it did not increase consultation time. These 9 professionals would recommend the app to their patients.
Conclusions: This evaluation of a supportive health app shows positive experiences among patients and their medical teams. Based on experiences in this study, patients may need to be actively encouraged to regularly register symptoms within health apps to generate sufficient patient-reported app data for use in clinical practice and scientific research.
Keywords: PROs; breast cancer; health apps; patient-reported outcomes; quality of life.
©Danny A Young-Afat, Carla H van Gils, David J Bruinvels, Carmen C van der Pol, Arjen J Witkamp, Sieta Sijtsema, Yvette Jonasse, Rhodé M Bijlsma, Margreet G Ausems, Annelies M Bos, Desirée H van den Bongard, Helena M Verkooijen. Originally published in JMIR Cancer (http://cancer.jmir.org), 07.06.2016.
Conflict of interest statementConflicts of Interest: David J Bruinvels is Medical Director at Px HealthCare, the company that created and owns the OWise breast cancer app. He is currently not employed by Px HealthCare and is a minor shareholder of Px HealthCare. The first and last author vouch for the integrity of this manuscript.
FiguresFigure 1
Screenshot of the OWise app…
Figure 1
Screenshot of the OWise app (day overview).
Figure 1Screenshot of the OWise app (day overview).
Figure 2
Screenshot of the OWise app…
Figure 2
Screenshot of the OWise app (week overview).
Figure 2Screenshot of the OWise app (week overview).
Figure 3
Example of a graphical overview…
Figure 3
Example of a graphical overview of patient-reported outcomes as obtained from the OWise…
Figure 3Example of a graphical overview of patient-reported outcomes as obtained from the OWise app's symptom registration function. The levels of nausea, sleep quality, and fatigue range from minimum (0) to maximum (100). A vertical line corresponds with the input of data by the patient. This patient received chemotherapy between August 2013 and December 2013. This data was provided by Px HealthCare with written permission from the patient.
Similar articlesRincon E, Monteiro-Guerra F, Rivera-Romero O, Dorronzoro-Zubiete E, Sanchez-Bocanegra CL, Gabarron E. Rincon E, et al. JMIR Mhealth Uhealth. 2017 Dec 4;5(12):e187. doi: 10.2196/mhealth.8741. JMIR Mhealth Uhealth. 2017. PMID: 29203459 Free PMC article. Review.
Ayre J, Bonner C, Bramwell S, McClelland S, Jayaballa R, Maberly G, McCaffery K. Ayre J, et al. JMIR Mhealth Uhealth. 2019 Jan 16;7(1):e11885. doi: 10.2196/11885. JMIR Mhealth Uhealth. 2019. PMID: 30664468 Free PMC article.
Berkowitz CM, Zullig LL, Koontz BF, Smith SK. Berkowitz CM, et al. JCO Clin Cancer Inform. 2017 Nov;1:1-7. doi: 10.1200/CCI.17.00107. JCO Clin Cancer Inform. 2017. PMID: 30657404
Eddy K, Jordan Z, Stephenson M. Eddy K, et al. JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843. JBI Database System Rev Implement Rep. 2016. PMID: 27532314 Review.
Lund-Jacobsen T, Schwarz P, Martino G, Pappot H, Piil K. Lund-Jacobsen T, et al. JMIR Res Protoc. 2024 Feb 15;13:e49549. doi: 10.2196/49549. JMIR Res Protoc. 2024. PMID: 38358787 Free PMC article.
Houghton LC, Howland RE, McDonald JA. Houghton LC, et al. Front Public Health. 2019 Nov 6;7:298. doi: 10.3389/fpubh.2019.00298. eCollection 2019. Front Public Health. 2019. PMID: 31781525 Free PMC article.
Vo V, Auroy L, Sarradon-Eck A. Vo V, et al. JMIR Mhealth Uhealth. 2019 Jul 10;7(7):e13817. doi: 10.2196/13817. JMIR Mhealth Uhealth. 2019. PMID: 31293246 Free PMC article.
Wright A. Wright A. Mhealth. 2021 Oct 20;7:60. doi: 10.21037/mhealth-20-161. eCollection 2021. Mhealth. 2021. PMID: 34805391 Free PMC article.
Merz A, Mohamed A, Corbett C, Herring K, Hildenbrand J, Locke SC, Patierno S, Troy J, Wolf S, Zafar SY, Chilcott J, Higgins A, Manassei H, McCoy C, Buckingham TL, LeBlanc TW. Merz A, et al. Support Care Cancer. 2022 Oct;30(10):7853-7861. doi: 10.1007/s00520-022-07224-x. Epub 2022 Jun 20. Support Care Cancer. 2022. PMID: 35718794 Clinical Trial.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3